Government: Page 65
-
Jacob Bell/Healthcare Dive
FDA warns of patient deaths tied to reusable urological endoscopes
The agency is sounding the alarm after receiving more than 450 adverse event reports in four years tying patient infections to the devices, as it continues to track contamination issues in duodenoscopes.
By Susan Kelly • Updated April 5, 2021 -
Shifting payer mix puts 340B hospitals at risk of losing eligibility
AHA wants HHS to waive certain eligibility requirements to allow continued access to the program during the public health emergency, the group wrote in a letter to Secretary Xavier Becerra.
By Hailey Mensik • April 1, 2021 -
Trendline
Labor
Hospitals are navigating persistent labor shortages with the need to cut costs — a source of contention that could leave patients caught in the middle.
By Healthcare Dive staff -
Adeline Kon/Healthcare Dive
A year into the pandemic, advanced cancer diagnoses are rising
Research from radiation oncologists and molecular pathologists add to evidence showing that many people skipped getting cancer screenings in 2020 as they avoided going to the doctor to minimize the risk of COVID-19 infection.
By Susan Kelly • March 31, 2021 -
FTC challenges Illumina-Grail deal, putting $7B merger in jeopardy
The commission said the union will "harm competition in the U.S. market for life-saving multi-cancer early detection tests." Illumina is opposing the action, but Wall Street analysts see no “easy fixes."
By Nick Paul Taylor • March 31, 2021 -
The image by Original image from Carol M. Highsmith’s America, Library of Congress collection is licensed under CC BY 2.0
Medical liability insurance premiums rising after stable decade, AMA report finds
While providers grapple with the pandemic's toll on finances, some can face liability premiums of $200,000 a year, according to the analysis sponsored by the doctors' lobby.
By Hailey Mensik • March 30, 2021 -
Permission granted by Bristol-Myers Squibb
FDA approves first CAR-T cell therapy for multiple myeloma
Approval of Bristol Myers Squibb and Bluebird bio's Abecma expands use of CAR-T treatment beyond leukemia and lymphoma.
By Ned Pagliarulo • March 29, 2021 -
Senate passes bill extending Medicare sequester cut pause
CMS instructed Medicare administrative contractors to hold all claims on or after April 1, when the pause on cuts is scheduled to end. The House is expected to take up the Senate-passed bill when it returns the week of April 13.
By Hailey Mensik • Updated March 31, 2021 -
Alex Wong via Getty Images
Hospitals flailed amid COVID-19 crisis, are unsure of future, OIG says
Executives said they were worried about their workers experiencing trauma and concerned a shrinking recruitment pool for nurses could exacerbate staffing shortages.
By Ron Shinkman • March 25, 2021 -
Courtesy of AstraZeneca
AstraZeneca, under fire, tries to repair image with new vaccine data
Updated results show the vaccine is only slightly less effective than AstraZeneca originally reported. But the drugmaker's unusual break with a study committee may have damaged perception of the shot.
By Ben Fidler • March 25, 2021 -
Permission granted by E.A. Crunden
As Medicare sequester cut extension deadline looms, AHA urges Senate to act
Without action, the 2% payment cuts to providers are slated to go back into effect April 1. The hospital lobby expects a vote this week.
By Hailey Mensik • March 24, 2021 -
AstraZeneca may have used 'outdated' data to describe vaccine's efficacy, NIH says
The British drugmaker said it will release updated data from the large U.S. trial within 48 hours, but the puzzling episode is another communication misstep for the company.
By Ned Pagliarulo • March 23, 2021 -
Cancer screenings bounced back after steep pandemic declines, Rand report shows
"These are the first findings to show that, despite real fears about the consequences of drop-off in cancer screens, health facilities figured out how to pick this back up after the initial pandemic restrictions," a researcher said.
By Samantha Liss • March 23, 2021 -
AstraZeneca, Oxford vaccine prevents COVID-19 in big US study amid controversy overseas
A two-shot regimen was 79% effective at protecting people from COVID-19, which should support the fourth clearance of a vaccine in the U.S. and calm safety concerns abroad.
By Ben Fidler • March 22, 2021 -
Yujin Kim/Healthcare Dive
Hospital mergers can slow wage growth for nurses, others: study
The Federal Trade Commission said it wants more analysis on the effects mergers have on labor markets and worker wages, though it typically challenges mergers that could up prices and distort care access.
By Samantha Liss • March 19, 2021 -
E.A. Crunden/Healthcare Dive
House passes bill that would extend Medicare sequester cuts until December
The cuts will go back into effect March 31 and the bill now awaits action from the Senate. The hospital industry has been pushing hard for a delay.
By Hailey Mensik • March 19, 2021 -
Retrieved from C-SPAN on February 24, 2021
Becerra confirmed as HHS secretary
The 50-49 vote in the Senate was almost entirely along party lines. The only Republican to cross the aisle was Sen. Susan Collins of Maine.
By Shannon Muchmore • March 18, 2021 -
Permission granted by Health Affairs
Q&AHealth Affairs' Alan Weil reflects on 1 year of COVID-19
The editor in chief of the respected industry journal spoke with Healthcare Dive about the role of equity in health research, the staying power of telemedicine and how to effectively communicate important public health messages.
By Shannon Muchmore • March 18, 2021 -
Brian Tucker/Healthcare Dive
FTC joins overseas antitrust regulators in reexamination of pharma M&A
Rebecca Kelly Slaughter, the commission's acting chair, indicated future reviews could look beyond measures of company size and market share.
By Jonathan Gardner • March 18, 2021 -
Adeline Kon/Healthcare Dive
Deep DiveIndependent primary care docs more financially stable, but fed up with vaccine exclusion
For the private practices that survived 2020, things have improved. But even as volumes recover, front-line physicians are still facing fresh challenges, including worries about downstream effects from delayed care.
By Rebecca Pifer • March 16, 2021 -
Despite pandemic, MedPAC advises few changes to 2022 provider payments
To the extent that the effects of the crisis are temporary and vary significantly depending on provider, they're best addressed through targeted yet temporary funding policies, the congressional advisers said in an annual report.
By Rebecca Pifer • March 16, 2021 -
Courtesy of Walmart
CMS hikes COVID-19 vaccine pay, broadens scope of providers to give jab
The AMA praised the boosted reimbursement, intended to speed up distribution of the three currently available shots.
By Shannon Muchmore • March 16, 2021 -
ECRI says COVID-19 has made racial disparities biggest healthcare safety concern
Overall preparedness for pandemic response and supply chain and drug shortage concerns also made the organization's annual top 10 list this year.
By Ron Shinkman • March 15, 2021 -
Alex Wong via Getty Images
The top drugs that could be impacted by an obscure provision in the pandemic relief law
Elimination of the so-called penny rule in Medicaid could force drugmakers to pay larger rebates on a number of top medicines, including some HIV, diabetes and anti-inflammatory drugs.
By Jonathan Gardner • March 15, 2021 -
adeline kon/Healthcare Dive, data from Adeline Kon / Healthcare Dive
COVID-19: 1 year later
For the healthcare industry, much has changed, and some of those alterations may be permanent. Hope is beginning to bloom as three coronavirus vaccines have been authorized for emergency use in the U.S.
March 15, 2021 -
S&P says risk of hospital operator defaults plummet from last year's highs
Officials credit coronavirus relief legislation for getting providers through the most difficult tumult of COVID-19 and keeping them financially stable even though patient volumes are still depressed.
By Ron Shinkman • March 12, 2021
Previous
